| |
| |
|
| Insider
Information: |
Behrens M Kathleen |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
371,047 |
|
|
Indirect Shares
|
400,313 |
|
|
| Direct
Value |
$22,980,729 |
|
|
|
Indirect Value
|
$1,228,400 |
|
|
| Total
Shares |
771,360 |
|
|
| Total
Value |
$24,209,129 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -4.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sarepta Therapeutics Inc |
SRPT |
|
2024-03-01 |
176,839 |
2024-03-01 |
10,000 |
Premium* |
|
|
Amylin Pharmaceuticals Inc |
AMLN |
Director |
2012-08-08 |
0 |
2011-05-24 |
0 |
Premium* |
|
|
Igm Biosciences, Inc. |
IGMS |
|
2024-03-29 |
10,046 |
2024-03-29 |
390,313 |
Premium* |
|
|
Mimedx Group Inc |
MDXG |
Director |
2024-06-05 |
184,162 |
2020-08-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
60 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLN |
Amylin Pharmaceuticals In... |
Director |
– • – |
2012-08-08 |
4 |
D |
$31.00 |
$186,000 |
D/D |
(6,000) |
0 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
211 |
1,850 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2021-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
211 |
2,061 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2021-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
211 |
2,272 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
374 |
2,646 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Director |
– • – |
2011-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
374 |
3,020 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
374 |
3,394 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
374 |
3,768 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2023-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
800 |
5,368 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2023-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
800 |
6,168 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2023-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
800 |
6,968 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2019-12-09 |
4 |
B |
$24.26 |
$497,316 |
I/I |
20,000 |
10,000 |
2.1 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
|
– • – |
2024-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
3,078 |
10,046 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2012-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
833 |
19,166 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2020-12-11 |
4 |
B |
$90.00 |
$3,999,960 |
I/I |
44,444 |
21,111 |
2.1 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2016-03-16 |
4 |
B |
$14.54 |
$145,433 |
I/I |
10,000 |
21,855 |
2.1 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-04-01 |
4 |
B |
$23.00 |
$1,399,987 |
I/I |
60,869 |
29,806 |
2.1 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2012-09-07 |
4 |
B |
$14.58 |
$257,724 |
D/D |
17,500 |
36,666 |
2.39 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2013-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
37,666 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2020-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
38,135 |
38,135 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2013-09-16 |
4 |
B |
$37.04 |
$240,778 |
D/D |
6,500 |
44,166 |
2.39 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
45,166 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2015-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
46,166 |
0 |
- |
|
60 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
